Welcome Guest
Home > Clinical Breast Cancer > Volume 2 |  Issue 1

Table of Contents

Volume 2 |  Issue 1

Publication Date: April 2001
  • Abstract Abstract
  • Full Text No Access
  • Full Text Pay-Per View
  • Full Text Full Text
  • Add to Cart Add to Cart


Editorial
Page Number of this Article in the Print Version
16		 A Seat at the Table
George W. Sledge, Jr
  • Abstract
  • No Access
  • Add to Cart
Meeting Highlights
Page Number of this Article in the Print Version
20-26		 2001 Highlights From: NIH Consensus Development Conference on Adjuvant Therapy for Breast Cancer, Bethesda, Maryland, November 1-3, 2000
Amy I. D’Orazio
  • Abstract
  • No Access
  • Add to Cart
Researches in Brief
Page Number of this Article in the Print Version
27-29		 Paclitaxel in the Adjuvant Setting: Results So Far Are Inconclusive
Amy I. D’Orazio, I. Craig Henderson, George W. Sledge, Joyce O’Shaugnessy
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
30-32		 Is HER2/neu Overexpression a Predictor of Anthracycline Utility?
Amy I. D’Orazio
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Review
Page Number of this Article in the Print Version
33-36		 Results and Implications of the Royal Marsden and Other Tamoxifen Chemoprevention Trials
Paul J. Ross, Trevor J. Powles
  • Abstract
  • No Access
  • Add to Cart
Commentaries
Page Number of this Article in the Print Version
37-38		 Commentary on “Results and Implications of the Royal Marsden and Other Tamoxifen Chemoprevention Trials”
Joseph A. Sparano
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
39-40		 Commentary on “Results and Implications of the Royal Marsden and Other Tamoxifen Chemoprevention Trials”
Carol Fabian
  • Abstract
  • No Access
  • Add to Cart
Comprehensive Review
Page Number of this Article in the Print Version
41-46		 Results and Implications of the Royal Marsden and Other Tamoxifen Chemoprevention Trials: An Alternative View
Joseph P. Costantino, Victor G. Vogel
  • Abstract
  • No Access
  • Add to Cart
Original Contributions
Page Number of this Article in the Print Version
47-51		 Activity of Pemetrexed (ALIMTA®, Multitargeted Antifolate, LY231514) in Metastatic Breast Cancer Patients Previously Treated with an Anthracycline and a Taxane: An Interim Analysis
Marc Spielmann, Miguel Martin, Moïse Namer, Andreas duBois, Clemens Unger, David J. Dodwell
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
52-58		 Interim Analysis of the Use of the Anti-Idiotype Breast Cancer Vaccine 11D10 (TriAb®) in Conjunction with Autologous Stem Cell Transplantation in Patients with Metastatic Breast Cancer
Donna E. Reece, Kenneth A. Foon, Malaya Battacharya-Chatterjee, Doug Adkins, E. Randolph Broun, D. Gerald Connaghan, John F. DiPersio, H. Kent Holland, Dianna S. Howard, Greg A. Hale, Hans G. Klingemann, Rita K. Munn, Anastasios Raptis, Gordon L. Phillips
  • Abstract
  • No Access
  • Add to Cart
Page Number of this Article in the Print Version
59-65		 Assessment of Axillary Lymph Node Involvement in Small Breast Cancer: Analysis of 893 Cases
Bruno Cutuli, Michel Velten, Caroline Martin
  • Abstract
  • No Access
  • Add to Cart
Commentary
Page Number of this Article in the Print Version
66		 Commentary on “Assessment of Axillary Lymph Node Involvement in Small Breast Cancer: Analysis of 893 Cases”
Douglas Reintgen
  • Abstract
  • No Access
  • Add to Cart
Brief Communication
Page Number of this Article in the Print Version
67-72		 Microvessel Density and p53 Overexpression in Young Women with Breast Cancer: A Case-Control Study
Barry Kalfon, Susan Fineberg, Yun Gu, Kanchana Anand, Ashish Dalal, Joan Jones, Joseph A. Sparano
  • Abstract
  • No Access
  • Add to Cart
Translational Medicine
Page Number of this Article in the Print Version
73-79		 Expansion of HER2/neu-Specific T Cells Ex Vivo Following Immunization with a HER2/neu Peptide-Based Vaccine
Keith L. Knutson, Mary L. Disis
  • Abstract
  • No Access
  • Add to Cart